Pancreatic endocrine tumors: Tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors

Radiology

Volumn 250, Issue 2, 2009, Pages 407-416

  D'Assignies, Gaspard ^a   Couvelard, Anne ^a   Bahrami, Stéphane ^b   Vullierme, Marie Pierre ^a   Hammel, Pascal ^a   Hentic, Olivia ^a   Sauvanet, Alain ^a   Bedossa, Pierre ^a   Ruszniewski, Philippe ^a   Vilgrain, Valerie ^a  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IOBITRIDOL; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFACT; BLOOD FLOWMETRY; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CORRELATION COEFFICIENT; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; INFORMED CONSENT; INTERMETHOD COMPARISON; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS BLOOD FLOW; PANCREAS ISLET CELL TUMOR; PERFUSION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; TUMOR BLOOD FLOW; TUMOR CALCINOSIS; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; ADOLESCENT; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; ENZYME IMMUNOASSAY; METHODOLOGY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PANCREAS TUMOR; PATHOLOGY; RADIOGRAPHY; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61749091581     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2501080291     Document Type: Article

References (40)

1. 1.Klöppel G, Heitz PU, Capella CES. Endocrine tumours of pancreas. In: Solcia E, KlOppel G, Sobin LH, eds. World Health Organization international histological classification of tumours: histological typing of endocrine tumours. 2nd ed. New York, NY: Springer-Verlag, 2000; 56-60.
2. Heitz PU, Komminoth P, Perren A, et al. World Health Organization classification of tumours. In: DeLellis R, Lloyd R, Heitz PU, Eng C, eds. Pathology and genetics of the tumours of endocrine organs. Lyon, France: IARC, 2004; 175-280.
3. Terris B. Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors [in French]. Ann Pathol 2002; 22:367-374.
4. Gentil Perret A, Mosnier JF, Buono JP, et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol 1998; 109:286-293.
5. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996;429:323-333.
6. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401.
7. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3:401-410.
8. Dumortier J, Ratineau C, Roche C, Lombard- Bohas C, Chayvialle JA, Scoazec JY. Angiogen- esis and endocrine tumors [in French]. Bull Cancer 1999;86:148-153.
9. Stafford-Johnson DB, Francis IR, Eckhauser FE, Knol JA, Chang AE. Dual-phase helical CT of nonfunctioning islet cell tumors. J Comput Assist Tomogr 1998;22:335-339.
10. Procacci C, Carbognin G, Accordini S, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol 2001;11:1175-1183.
11. Horton KM, Hruban RH, Yeo C, FishmanEK. Multi-detector row CT of pancreatic islet cell tumors. Radio Graphics 2006;26:453-464.
12. Fox SB. Tumour angiogenesis and prognosis. Histopathology 1997;30:294-301.
13. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003;125:1094-1104.
14. Couvelard A, O'Toole D, Turley H, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation ofmicrovascu- lar density and VEGF expression with tumour progression. Br J Cancer 2005;92:94-101.
15. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of an- giogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 2007;13:187-196.
16. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003; 76:220-231.
17. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171- 187.
18. Rodallec M, Vilgrain V, Couvelard A, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognos- tic factors and survival. Pancreatology 2006;6:77-85.
19. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005;234:785-792.
20. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helicalCTofsmallrenalparenchy- mal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24:835-842.
21. Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr 2001;25:23-27.
22. Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectalcancer. Nat Med 2004;10:145- 147.
23. Miles KA. Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76(spec no 1):S36-S42.
24. Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299 -1303.
25. Abe H, Murakami T, Kubota M, et al. Quantitative tissue blood flow evaluation of pancreatic tumor: comparison between xenon CT technique and perfusion CT technique based on deconvolution analysis. Radiat Med 2005;23:364-370.
26. Xue HD, Jin ZY, Liu W, Wang Y, Zhao WM. Perfusion characteristics of normal pancreas and insulinoma on multi-slice spiral CT [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006;28:68-70.
27. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early- stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
28. Vermeulen PB, Verhoeven D, Hubens G, et al. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas.Ann Oncol 1995;6:59-64.
29. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 1998;34:337-340.
30. Duarte IG, Bufkin BL, Pennington MF, et al. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1998; 115:652-658.
31. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemody- namics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462-470.
32. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46: 3161-3175.
33. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology 2007;243:736-743.
34. Goh V, Halligan S, Taylor SA, Burling D, Bassett P, Bartram CI. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria-initial experience. Radiology 2007;242:456-462.
35. Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DA. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr 1999;23:540-547.
36. Kubota M, Dono K, Hashimoto K. Evaluation between tissue blood flow of pancreatic cancer and therapeutic effect of chemoradia- tion therapy with Xenon CT [in Japanese]. Presented at the 58th annual meeting of the Japanese Society of Gastroenterological Surgery, Sapporo, Japan, July 2003.
37. Falconi M, Plockinger U, Kwekkeboom DJ, et al. Well-differentiated pancreatic non- functioning tumors/carcinoma. Neuroendocrinology2006;84:196-211.
38. Hakime A, Peddi H, Hines-Peralta AU, et al. CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology2007;243:712-719.
39. Sanelli PC, Nicola G, Tsiouris AJ, et al. Re- producibility of postprocressing of quantitative CT perfusion maps. AJR Am J Roentgenol 2007;188:213-218.
40. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284.